IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kan-Mitchell, J.
Right arrow Articles by Danenberg, P. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kan-Mitchell, J.
Right arrow Articles by Danenberg, P. V.

Investigative Ophthalmology & Visual Science, Vol 34, 3366-3375, Copyright © 1993 by Association for Research in Vision and Ophthalmology


ARTICLES AND REPORTS

Differential S100 beta expression in choroidal and skin melanomas: quantitation by the polymerase chain reaction

J Kan-Mitchell, PE Liggett, CR Taylor, N Rao, ES Granada, KD Danenberg, WL White, LJ Van Eldik, T Horikoshi and PV Danenberg
Department of Pathology, University of Southern California School of Medicine, Los Angeles 90033.

PURPOSE. S100 beta, a member of a calcium-binding protein family (S100s), is an important clinical marker for skin melanoma. In contrast, uveal melanomas appeared to express S100 beta protein less frequently and to a lesser degree. This study was performed to verify and extend this finding to the mRNA level. METHODS. A quantitative polymerase chain reaction (PCR)-based method was used. A ratio, comparing the S100 beta PCR fragment to that of beta-actin (an internal reference gene), was generated to compare S100 beta mRNA expression among samples. RESULTS. The ratios for skin melanomas (1.2 to 3.9; three tissues and two cell lines) were significantly higher than that for choroidal melanomas (0.1 to 0.63; seven of eight primary tumors and four of four cell lines). Only one choroidal melanoma biopsy had a ratio greater than 1. The PCR products from choroidal melanoma were identical in size and sequence to the S100 beta, as determined by gel electrophoresis and RNA conformational polymorphism. Because the ratios were also low in choroidal melanoma cell lines, the S100 beta phenotype appears to be genetically stable. CONCLUSION. S100 beta is differentially expressed at the RNA and protein levels by skin and choroidal melanomas, which are derived from distinct populations of melanocytes. However, choroidal melanomas expressing little or no S100 beta were significantly stained by antiserum specific for the S100 protein family. Taken together, these data suggest that choroidal melanocytes express another, perhaps even novel, S100 protein(s).


This article has been cited by other articles:


Home page
Arch OphthalmolHome page
G. S. O. A. Missotten, N. E. M. L. Tang, C. M. Korse, H. M. H. Hurks, D. de Wolff-Rouendaal, J. E. E. Keunen, M. J. Jager, and J. M. G. Bonfrer
Prognostic Value of S-100-{beta} Serum Concentration in Patients With Uveal Melanoma
Arch Ophthalmol, August 1, 2003; 121(8): 1117 - 1119.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
S. Iwamoto, R. C. Burrows, R. E. Kalina, D. George, M. Boehm, M. A. Bothwell, and R. Schmidt
Immunophenotypic Differences Between Uveal and Cutaneous Melanomas
Arch Ophthalmol, April 1, 2002; 120(4): 466 - 470.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. S. Mitchell, J. Kan-Mitchell, B. Minev, C. Edman, and R. J. Deans
A Novel Melanoma Gene (MG50) Encoding the Interleukin 1 Receptor Antagonist and Six Epitopes Recognized by Human Cytolytic T Lymphocytes
Cancer Res., November 1, 2000; 60(22): 6448 - 6456.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the Association for Research in Vision and Ophthalmology